A fetus with cystic fibrosis was treated in utero with elexacaftor/tezacaftor/ivacaftor to prevent meconium ileus. 

The following CHOP clinicians recently joined our team.

In recent years, recognition of autism and autism spectrum disorders (ASD) in the general population has burgeoned.

Christopher S. Thom, MD, PhD, is an attending physician and principal investigator in the Division of Neonatology at Children’s Hospital of Philadelphia (CHOP).

It’s an exciting time for research in the bronchopulmonary dysplasia (BPD) population here at Children’s Hospital of Philadelphia (CHOP). 

The increase in opioid use disorder among adults across the U.S. includes pregnant people, with an associated increase in substance-exposed newborns.

Our second inpatient location — the Middleman Family Pavilion on CHOP’s campus in King of Prussia, Pa., a suburb just outside of Philadelphia — opened in early 2022. 

Quick-Mitome, developed by an international consortium of mitochondrial disease specialists, is available for non-commercial, non-clinical research.

This recognition from Press Ganey, a company that helps healthcare providers and health plans transform the Human Experience, highlights Bell's unwavering commitment to providing high-quality care to children and families.

Meet Joseph L. Yellin, MD, an attending pediatric orthopaedic surgeon in the Division of Orthopaedics and Sports Medicine and Performance Center at CHOP.